The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
LIBELULE: A randomized phase III study to evaluate the clinical relevance of early liquid biopsy (LB) in patients with suspicious metastatic lung cancer.
 
Aurélie Swalduz
Honoraria - Amgen; AZD; Boehringer Ingelheim; Roche
Consulting or Advisory Role - Amgen; AstraZeneca/MedImmune; Bristol-Myers Squibb/Medarex; Janssen; Roche
Travel, Accommodations, Expenses - Boehringer Ingelheim; Janssen
 
Hubert Curcio
Honoraria - Bristol-Myers Squibb
Travel, Accommodations, Expenses - Sandoz
 
Bana Ambasager
Employment - Inivata; NeoGenomics Laboratories
 
Gabriel Le Moel
No Relationships to Disclose
 
Didier Debieuvre
Honoraria - AstraZeneca; BMS France; GlaxoSmithKline; MSD Oncology; Novartis; Pfizer; Roche
Consulting or Advisory Role - Amgen; BMS France; Ipsen; Janssen; MSD Oncology; Novartis; OSE Immunotherapeutics; Pfizer; Sanofi/Aventis
Research Funding - AstraZeneca (Inst); Bayer (Inst); BMS france (Inst); Boehringer Ingelheim (Inst); Chiesi (Inst); Chugai Pharma (Inst); GlaxoSmithKline (Inst); Janssen (Inst); Lilly (Inst); MSD Oncology (Inst); Novartis (Inst); OSE Immunotherapeutics (Inst); Pfizer (Inst); Roche (Inst); Sanofi (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - AstraZeneca; BMS france; BMS france; BMS France; Boehringer Ingelheim; Boehringer Ingelheim France; Lilly (Inst); MSD Oncology; MSD Oncology (Inst); Novartis; novartis France; Pfizer; Roche; Roche; Takeda
 
Jean Marc Dot
No Relationships to Disclose
 
Michaël Duruisseaux
Honoraria - Amgen; AstraZeneca; BMSi; Elevation Oncology; GlaxoSmithKline; Guardant Health; Janssen Oncology; MSD; Roche; Takeda
Consulting or Advisory Role - Amgen; AstraZeneca; BMSi; Elevation Oncology; GlaxoSmithKline; Janssen; Lilly O.; MSD; Roche; Takeda
Research Funding - Lilly O.
Travel, Accommodations, Expenses - Janssen; Roche
 
Pierre Fournel
Consulting or Advisory Role - Amgen; AstraZeneca; Bristol-Myers Squibb; Lilly; MSD Oncology; Takeda
Speakers' Bureau - Amgen; AstraZeneca; Bristo-Myers-Squibb; Lilly; MSD Oncology; Pfizer; Roche
Research Funding - Amgen (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst)
Travel, Accommodations, Expenses - Amgen; AstraZeneca; Bristol-Myers Squibb; MSD Oncology; Takeda
 
Luc Odier
Travel, Accommodations, Expenses - Pfizer
 
Sylvie Demolombe
No Relationships to Disclose
 
Acya Bizieux-Thamany
No Relationships to Disclose
 
Annie Peytier
No Relationships to Disclose
 
Roland Schott
Consulting or Advisory Role - Roche
Travel, Accommodations, Expenses - Pfizer; Roche; Takeda
 
Stephane Hominal
No Relationships to Disclose
 
Mathilde Donnat
No Relationships to Disclose
 
Sandra Ortiz Cuaran
No Relationships to Disclose
 
Camille Schiffler
No Relationships to Disclose
 
Nitzan Rosenfeld
Employment - Inivata; NeoGenomics Laboratories; Storm Therapeutics (I)
Leadership - Inivata
Stock and Other Ownership Interests - Mission Therapeutics (I); NeoGenomics Laboratories; Storm Therapeutics (I)
Patents, Royalties, Other Intellectual Property - Inivata
 
Pierre Saintigny
Honoraria - Archer; Bristol Myer Squibb; HTG Molecular Diagnostics; Inivata; Roche Molecular Diagnostics
Research Funding - AstraZeneca; BMS Foundation; Illumina; Novartis; Omicure (Inst); Roche
Travel, Accommodations, Expenses - AstraZeneca; Bristol Myer Squibb; Illumina; Roche
 
Maurice Perol
Consulting or Advisory Role - Amgen; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Chugai Pharma; Daïchi Sankyo; GlaxoSmithKline; Gritstone Bio; Janssen Oncology; Lilly; Merck Sharp & Dohme; Novartis; Pfizer; Roche/Genentech; Sanofi; Takeda
Research Funding - AstraZeneca (Inst); Boehringer Ingelheim (Inst); Roche (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb; Chugai Pharma; Merck Sharp & Dohme; Pfizer; Roche; Takeda